Aripiprazole

Chemical formula: C₂₃H₂₇Cl₂N₃O₂  Molecular mass: 448.385 g/mol  PubChem compound: 60795

Therapeutic indications

Aripiprazole is indicated for:

Schizophrenia

Population group: only adults (18 years old or older)

Aripiprazole is indicated for the treatment of schizophrenia in adults.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Manic episodes in Bipolar I Disorder and recurrence prevention

Population group: only adults (18 years old or older)

at least one of
Manic bipolar I disorder
Preventive procedure and additionally Manic bipolar I disorder

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Schizophrenia

Population group: only adolescents (12 years - 18 years old)

Aripiprazole is indicated for the treatment of schizophrenia in adults.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Manic episodes in Bipolar I Disorder

Population group: only adolescents (12 years - 18 years old)

Manic bipolar I disorder

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2018: ABILIFY Tablet
Summary of Product Characteristics (SPC) 2018: ABILIFY Solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈